CeMMEC13
CeMMEC13 is a potent inhibitor of TAF1 (2) bromodomain, with an IC50 of 2.1 μM.
Product Specifications
CAS Number
1790895-25-8
UNSPSC
12352005
Hazard Statement
H302, H315, H319, H335
Target
DNA/RNA Synthesis
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CeMMEC13.html
Concentration
10mM
Purity
98.0
Solubility
DMSO : 16.67 mg/mL (ultrasonic)
Smiles
O=C(C1=CC(N(C)C2=C1C=CC=C2)=O)NC3=CC=C(OCCO4)C4=C3
Molecular Formula
C19H16N2O4
Molecular Weight
336.34
Precautions
H302, H315, H319, H335
References & Citations
[1]Sdelci S, et al. Mapping the chemical chromatin reactivation landscape identifies BRD4-TAF1 cross-talk. Nat Chem Biol. 2016 Jul;12 (7) :504-10.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
![NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 Polyclonal Conjugated Antibody](https://cdn.genprice.uk/genprice/uk/genprice5.webp)
orb1617923 100 µL
NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 3 Polyclonal Conjugated Antibody
Sign In for Pricing
View Details